002107SZSE

Announcement on Estimated Daily Related Transactions for 2026

WoHua Pharmaceuticals Co., Ltd.··5 pages

✨ AI Summary

Shandong Wohua Pharmaceutical Technology Co., Ltd. announced the estimated daily related transactions for 2026, involving a processing service to Tonghua Weijing Pharmaceutical Co., Ltd. valued at approximately 8 million yuan. The transactions are based on market pricing principles and are expected to utilize excess production capacity, enhancing revenue and profits without impacting the company's independence or financial stability. The independent directors have approved the proposal.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Announcement on Estimated Daily Related Transactions for 2026

Shandong Wohua Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Wohua Pharmaceutical" or "the Company") held the seventh meeting of the eighth board of directors on January 19, 2026, and approved the proposal on estimated daily related transactions for 2026. The specific details are announced as follows:

1. Basic Information on Daily Related Transactions

(1) Overview of Daily Related Transactions

According to the needs of the Company's production and operation, the Company will engage in daily related transactions with the related party Tonghua Weijing Pharmaceutical Co., Ltd. (hereinafter referred to as "Weijing Pharmaceutical"), involving the provision of processing services to the related party, with an estimated amount of 8 million yuan.

(2) Estimated Categories and Amounts of Daily Related Transactions

Related Transaction CategoryRelated PartyRelated Transaction ContentPricing PrincipleEstimated AmountAmount Incurred as of Disclosure DateAmount Incurred Last Year
Provision of processing servicesTonghua Weijing Pharmaceutical Co., Ltd.Provision of processing servicesMarket price principle800.005.61513.54

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.